REAL-WORLD EVIDENCE RECOMMENDATIONS FOR GENE THERAPIES: REGULATORY VERSUS HEALTH TECHNOLOGY ASSESSMENT

被引:0
|
作者
Allen, G. [1 ]
Summers, D. M. [1 ]
Evans, J. [1 ]
机构
[1] Costello Med, Cambridge, England
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
PBI43
引用
收藏
页码:S21 / S21
页数:1
相关论文
共 50 条
  • [31] A perspective on life-cycle health technology assessment and real-world evidence for precision oncology in Canada
    Regier, Dean A.
    Pollard, Samantha
    McPhail, Melanie
    Bubela, Tania
    Hanna, Timothy P.
    Ho, Cheryl
    Lim, Howard J.
    Chan, Kelvin
    Peacock, Stuart J.
    Weymann, Deirdre
    NPJ PRECISION ONCOLOGY, 2022, 6 (01)
  • [32] A perspective on life-cycle health technology assessment and real-world evidence for precision oncology in Canada
    Dean A. Regier
    Samantha Pollard
    Melanie McPhail
    Tania Bubela
    Timothy P. Hanna
    Cheryl Ho
    Howard J. Lim
    Kelvin Chan
    Stuart J. Peacock
    Deirdre Weymann
    npj Precision Oncology, 6
  • [33] Emulating Trials and Quantifying Bias: The Convergence of Health Technology Assessment Agency Real-World Evidence Guidance
    Chen, Simon
    Tikhonovsky, Natalie
    Dhanji, Nishit
    Ramagopalan, Sreeram
    VALUE IN HEALTH, 2024, 27 (02) : 265 - 267
  • [34] RESTRICTIONS AND REAL-WORLD EVIDENCE REQUIREMENTS IN THE HEALTH TECHNOLOGY ASSESSMENT OF GENE THERAPY MEDICINAL PRODUCTS IN EUROPE, CANADA, AUSTRALIA, AND THE UNITED STATES
    Hubscher, E.
    Wiltshire, L.
    Young, H. H., I
    Brackley, A.
    Ko, S.
    VALUE IN HEALTH, 2022, 25 (12) : S300 - S300
  • [35] Randomization versus Real-World Evidence REPLY
    Collins, Rory
    Bowman, Louise
    Landray, Martin
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (04):
  • [36] THE RACE TO IMPROVE HEALTH TECHNOLOGY ASSESSMENT OF GENE THERAPIES: WHICH COUNTRIES ARE EMBRACING RECOMMENDATIONS?
    Besley, S.
    Henderson, N.
    Napier, M.
    Hampson, G.
    Cole, A.
    Diamond, L.
    Gassman, S.
    Fortier, D.
    Kim, R.
    VALUE IN HEALTH, 2023, 26 (12) : S384 - S384
  • [37] The Use of Real-World Evidence for Regulatory Decisions in China
    Xu, Jiayue
    Wu, Wenkai
    Zhang, Xia
    Ren, Yan
    Yao, Minghong
    Liu, Mei
    Zou, Kang
    Wang, Wen
    Sun, Xin
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 116 (01) : 82 - 95
  • [38] The use of real-world data/evidence in regulatory submissions
    Song, Fuyu
    Zang, Chenxuan
    Ma, Xinyi
    Hu, Sifan
    Sun, Qiqing
    Chow, Shein-Chung
    Sun, Hongqiang
    CONTEMPORARY CLINICAL TRIALS, 2021, 109
  • [39] Modernizing Regulatory Evidence with Trials and Real-World Studies
    Nancy A. Dreyer
    Marni Hall
    Jennifer B. Christian
    Therapeutic Innovation & Regulatory Science, 2020, 54 : 1112 - 1115
  • [40] Modernizing Regulatory Evidence with Trials and Real-World Studies
    Dreyer, Nancy A.
    Hall, Marni
    Christian, Jennifer B.
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2020, 54 (05) : 1112 - 1115